title: Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Massy
authors.forename: J P
authors.initials: JP
authors.lastname: De Bandt
authors.forename: E
authors.initials: E
authors.lastname: Morelon
authors.forename: M
authors.initials: M
authors.lastname: Thevenin
authors.forename: B
authors.initials: B
authors.lastname: Lacour
authors.forename: H
authors.initials: H
authors.lastname: Kreis
mesh_terms: D001053:Apolipoproteins / Q000097:blood; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008071:Lipoprotein Lipase / Q000097:blood*; D011183:Postoperative Complications; D020123:Sirolimus / Q000009:adverse effects*; D014280:Triglycerides / Q000097:blood
chemical_list: D001053:Apolipoproteins; D008076:Cholesterol, HDL; D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D008071:Lipoprotein Lipase; D020123:Sirolimus